Your browser doesn't support javascript.
loading
Behavioural-variant frontotemporal dementia: an update / Demência frontotemporal-variante comportamental: uma revisão
Piguet, Olivier; Hodges, John R.
  • Piguet, Olivier; University of New South Wales. School of Medical Sciences. Sydney. AU
  • Hodges, John R; University of New South Wales. School of Medical Sciences. Sydney. AU
Dement. neuropsychol ; 7(1): 10-18, jan.-mar. 2013. tab
Article in English | LILACS | ID: lil-670729
ABSTRACT
Behavioural-variant frontotemporal dementia (bvFTD) is characterised by insidious changes in personality and interpersonal conduct that reflect progressive disintegration of the neural circuits involved in social cognition, emotion regulation, motivation and decision making. The underlying pathology is heterogeneous and classified according to the presence of intraneuronal inclusions of tau, TDP-43 or occasionally FUS. Biomarkers to detect these histopathological changes in life are increasingly important with the development of disease-modifying drugs. Gene mutations have been found which collectively account for around 10-20% of cases including a novel hexanucleotide repeat on chromosome 9 (C9orf72). The recently reviewed International Consensus Criteria for bvFTD propose three levels of diagnostic certainly: possible, probable and definite. Detailed history taking from family members to elicit behavioural features underpins the diagnostic process with support from neuropsychological testing designed to detect impairment in decision-making, emotion processing and social cognition. Brain imaging is important for increasing the level of diagnosis certainty. Carer education and support remain of paramount importance.
RESUMO
Demência frontotemporal-variante comportamental (DFTvc) é caracterizada por mudanças insidiosas de personalidade e conduta interpessoal, que refletem a desintegração progressiva de circuitos neurais envolvidos em cognição social, regulação emocional, motivação e tomada de decisão. O substrato patológico é heterogêneo e classificado de acordo com a presença de inclusões intraneuronais de proteína tau, TDP-43 ou, ocasionalmente, de FUS. Biomarcadores capazes de detectar estas alterações histopatológicas durante a vida vêm ganhando importância com o desenvolvimento de drogas específicas modificadoras da doença. Algumas mutações genéticas já foram encontradas, sendo em conjunto responsáveis por 10-20% dos casos, incluindo a recentemente descrita repetição de hexanucleotídeo no cromossomo 9 (C9orf72). A versão revisada dos Critérios Internacionais do Consenso em DFTvc propõe três níveis de certeza diagnóstica: possível, provável e definida. História clínica detalhada obtida com familiares, para identificar as alterações de comportamento características, auxilia no diagnóstico, juntamente com o apoio de avaliação neuropsicológica dirigida à detecção de comprometimento em tarefas de tomada de decisão, processamento emocional e cognição social. A neuroimagem é importante para aumentar o grau de certeza diagnóstica. Educação e suporte dos cuidadores continuam sendo medidas de extrema relevância.
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Cognition / Frontotemporal Dementia / Neuroimaging / Genetics Type of study: Prognostic study Limits: Humans Language: English Journal: Dement. neuropsychol Journal subject: NEUROCIENCIAS / Neurology / Psychology / Psychiatry Year: 2013 Type: Article Affiliation country: Australia Institution/Affiliation country: University of New South Wales/AU

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Cognition / Frontotemporal Dementia / Neuroimaging / Genetics Type of study: Prognostic study Limits: Humans Language: English Journal: Dement. neuropsychol Journal subject: NEUROCIENCIAS / Neurology / Psychology / Psychiatry Year: 2013 Type: Article Affiliation country: Australia Institution/Affiliation country: University of New South Wales/AU